---
title: "REG - Intnl. Biotechnology - Net Asset Value(s)"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/276434283.md"
description: "International Biotechnology Trust PLC announced its unaudited net asset values (NAV) per share as of February 19, 2026. The NAV Ex Income is 1020.60 pence, and the NAV Cum Income is 987.70 pence. These values were calculated following the recommendations of the Association of Investment Companies. For inquiries, contact Schroder Investment Management Limited."
datetime: "2026-02-20T10:53:51.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/276434283.md)
  - [en](https://longbridge.com/en/news/276434283.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/276434283.md)
---

# REG - Intnl. Biotechnology - Net Asset Value(s)

RNS Number : 8639T Intl. Biotechnology Trust PLC 20 February 2026 International Biotechnology Trust plcNet Asset Values The Board of International Biotechnology Trust PLC (the "Company") announces the unaudited net asset value ("NAV") per share of the Company as follows:

Date

NAV

Pence

Thursday 19 Feb

Ex Income

1020.60

Thursday 19 Feb

Cum Income

987.70

The above NAVs have been calculated in accordance with the recommendations of the Association of Investment Companies. 20-Feb-2026 Enquiries: International Biotechnology Trust plc Schroder Investment Management Limited Company Secretary 0207 658 6501 This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy. END NAVPPUGAPUPQGUU

### Related Stocks

- [IBT.UK](https://longbridge.com/en/quote/IBT.UK.md)
- [BIOM.UK](https://longbridge.com/en/quote/BIOM.UK.md)

## Related News & Research

- [REG - Intnl. Biotechnology - Net Asset Value(s)](https://longbridge.com/en/news/275450470.md)
- [REG - Intnl. Biotechnology - Net Asset Value(s)](https://longbridge.com/en/news/274509800.md)
- [Simeon George Discloses Investment at Odyssey Therapeutics with 8.0% Stake](https://longbridge.com/en/news/286825924.md)
- [REG - Intnl. Biotechnology - Net Asset Value(s)](https://longbridge.com/en/news/273837354.md)
- [Vericel Corporation $VCEL Stock Position Reduced by Truist Financial Corp](https://longbridge.com/en/news/286758697.md)